作者
Karl Claxton, Steve Martin, Marta Soares, Nigel Rice, Eldon Spackman, Sebastian Hinde, Nancy Devlin, Peter C Smith, Mark Sculpher
发表日期
2015/2
期刊
Health Technology Assessment (Winchester, England)
卷号
19
期号
14
页码范围
1
出版商
Various
简介
BACKGROUND
Cost-effectiveness analysis involves the comparison of the incremental cost-effectiveness ratio of a new technology, which is more costly than existing alternatives, with the cost-effectiveness threshold. This indicates whether or not the health expected to be gained from its use exceeds the health expected to be lost elsewhere as other health-care activities are displaced. The threshold therefore represents the additional cost that has to be imposed on the system to forgo 1 quality-adjusted life-year (QALY) of health through displacement. There are no empirical estimates of the cost-effectiveness threshold used by the National Institute for Health and Care Excellence.
OBJECTIVES
(1) To provide a conceptual framework to define the cost-effectiveness threshold and to provide the basis for its empirical estimation.(2) Using programme budgeting data for the English NHS, to estimate the relationship …
引用总数
2013201420152016201720182019202020212022202320241432539713612411411690778755
学术搜索中的文章
K Claxton, S Martin, M Soares, N Rice, E Spackman… - Health Technology Assessment (Winchester, England), 2015
K Claxton, S Martin, M Soares, N Rice, E Spackman… - Centre for Health Economics Research Paper, 2013